Ethical considerations in end-of-life care and research

Journal of Palliative Medicine

Volumn 8, Issue SUPPL. 1, 2005, Pages

  Casarett, David ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; PALLIATIVE THERAPY; PATIENT DECISION MAKING; PATIENT PARTICIPATION; QUALITY OF LIFE; RESEARCH ETHICS; RISK ASSESSMENT; STANDARD; TERMINAL CARE; TOTAL QUALITY MANAGEMENT; VALIDITY;

BENEFICENCE; DECISION MAKING; EMPIRICAL RESEARCH; ETHICS, RESEARCH; HUMAN EXPERIMENTATION; HUMANS; MENTAL COMPETENCY; PALLIATIVE CARE; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; RESEARCH SUBJECTS; STRESS, PSYCHOLOGICAL; TERMINAL CARE;

EID: 32044433532     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. Symptoms in Terminal Illness: A Research Workshop. September 22-3, 1997, Rockville, MD.
2. Mount B, Cohen R, MacDonald N, Bruera E, Dudgeon D: Ethical issues in palliative care research revisited. Palliat Med 1995;9:165-170.
3. Field MJ, Cassell CK (eds): Approaching Death. Improving Care at the End of Life. Washington, DC: National Academy Press, 1997.
4. Department of Health and Human Services: Protection of Human Subjects. Title 45 Part 46: Revised. Code of Federal Regulations. June 18, 1991.
5. de Raeve L: Ethical issues in palliative care research. Palliat Med 1994;8:298-305.
6. Annas GJ: Some Choice: Law, Medicine, and the Market. New York: Oxford University Press, 1998.
7. Casarett D, Karlawish J: Are special ethical guidelines needed for palliative care research? J Pain Symptom Manage 2000;20:130-139.
8. Hilts PJ: VA hospital is told to halt all research. New York Times, March 25, 1999.
9. Casarett D, Knebel A, Helmers K: Ethical challenges of palliative care research. J Pain Symptom Manage 2003;25:S3-S5.
10. Casarett D, Karlawish J, Sugarman J: Determining when quality improvement activities should be reviewed as research: Proposed criteria and potential implications. JAMA 2000;283:2275-2280.
11. Lynn J, Johnson J, Levine RJ: The ethical conduct of health services research: A case study of 55 institutions' applications to the SUPPORT project. Clin Res 1994;42:3-10.
12. Brett A, Grodin M: Ethical aspects of human experimentation in health services research. JAMA 1991; 265:1854-1857.
13. Truog RD, Robinson W, Randolph A: Is informed consent always necessary for randomized, controlled trials? NEJM 1999;340:804-807.
14. Cretin S, Keeler EB, Lynn J, Batalden PB, Berwick DM, Bisognano M: Should patients in quality-improvement activities have the same protections as participants in research studies? JAMA 2000;284:1786.
15. Freedman B: Scientific value and validity as ethical requirements for research: a proposed explication. IRB 1987;9:7-10.
16. Rutstein DR: The ethical design of human experiments. In: Freund PA (ed): Experimentation With Human Subjects. New York: George Braziller, 1970: 383-401.
17. Silverman DG, O'Connor TZ, Brull SJ: Integrated assessment of pain scores and rescue morphine use during studies of analgesic efficacy. Anesth Analg 1993;77:168-170.
18. Casarett D, Karlawish J, Moreno J: A taxonomy of value in clinical research. IRB 2003;24:1-6.
19. Emanuel EJ, Wendler D, Grady C: What makes clinical research ethical? JAMA 2000;283:2701-2711.
20. World Medical Association. Declaration of Helsinki. Available at http://www.wma.net/e/policy/17-c_e. html. 〈Last accessed November 3, 2005.〉
21. The Nuremberg Code: Reprinted in: Brody B: The Ethics of Biomedical Research. An International Perspective. New York: Oxford University Press, 1947, p. 213.
22. Freedman B: Placebo-controlled trials and the logic of clinical purpose. IRB 1990;12:1-6.
23. Advisory Committee on Human Radiation Experiments: Final Report. Vol 061 00000848-9. Washington, DC: Government Printing Office, 1995.
24. Meinert CL: Clinical Trials. Design, Conduct, and Analysis. Oxford: Oxford University Press, 1986.
25. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ: Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78:209-216.
26. Crowley R, Casarett D: Patients' willingness to participate in symptom-related and disease-modifying research: Results of a screening initiative in a palliative care clinic. Cancer 2003;97:2327-2333.
27. Casarett D, Kassner CT, Kutner JS: Recruiting for research in hospice: Feasibility of a research screening protocol. J Palliat Med (in press).
28. Casarett D: How are hospice patients referred from academic medical centers different? J Pain Symptom Manage 2001;27:197-203.
29. Casarett D, Kirschling J, Levetown M, Merriman M, Ramey M, Silverman P: NHPCO Task Force Statement on Hospice Participation in Research. J Palliat Med 2001;4:441-449.
30. Du Pen SL, Du Pen AR, Polissar N, et al: Implementing guidelines for cancer pain management: Results of a randomized controlled clinical trial. J Clin Oncol 1999;17:361-370.
31. Ahmedzai S, Brooks D: Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage 1997;13:254-261.
32. Farrar JT, Cleary J, Rauck R, Busch M, Nordbrock E: Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Nat Cane Inst 1998;90:611-616.
33. Freedman B: Equipoise and the ethics of clinical research. NEJM 1987;317:141-145.
34. Ingham J, Seidman A, Yao TJ, Lepore J, Portenoy R: An exploratory study of frequent pain measurement in a cancer clinical trial. Qual Life Res 1996;5:503-507.
35. Twycross R, Harcourt J, Bergl S: A survey of pain in patients with advanced cancer. J Pain Symptom Manage 1996;12:273-282.
36. Parmelee PA, Smith B, Katz IR: Pain complaints and cognitive status among elderly institution residents. J Am Geriatr Soc 1993;41:517-522.
37. Ward SE, Gordon DB: Patient satisfaction and pain severity as outcomes in pain management: A longitudinal view of one setting's experience. J Pain Symptom Manage 1996;11:242-251.
38. Desbiens NA, Wu AW, Broste SK, et al: Pain and satisfaction with pain control in seriously ill hospitalized adults: Findings from the SUPPORT research investigations. For the SUPPORT investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Crit Care Med 1996;24: 1953-1961.
39. Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R, Mahmoud R: Quality of life and cancer pain: Satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol 1998;16:1588-1593.
40. Derogatis LR, Morrow GR, Fetting J, et al: The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751-757.
41. Kathol RG, Mutgi A, Williams J, Clamon G, Noyes R: Diagnosis of depression in cancer patients according to four sets of criteria. Am J Psychiatry 1990;147: 1021-1024.
42. Heiskanen T, Kalso E: Controlled-release oxycodone and morphine in cancer related pain. Pain 1997;73: 37-45.
43. Deschamps M, Band PR, Hislop G, Rusthoven J, Iscoe N, Warr D: The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine. J Pain Symptom Manage 1992;7:384-392.
44. Casarett DJ, Karlawish J, Sankar P, Hirschman K, Asch DA: Should open label extension studies be required in the design of clinical drug trials? IRB 2001;23:1-5.
45. Freedman B, Fuks A, Weijer C: Demarcating research and treatment: A systematic approach for the analysis of the ethics of clinical research. Clin Res 1992;40:653-660.
46. Kirkham SR, Abel J: Placebo-controlled trials in palliative care: The argument against. Palliat Med 1997; 11:489-492.
47. Hardy JR: Placebo-controlled trials in palliative care: The argument for. Palliat Med 1997;11:415-418.
48. Macklin R: The ethical problems with sham surgery in clinical research. NEJM 1999;341:992-996.
49. Rothman KJ, Michels KB: The continuing unethical use of placebo controls. NEJM 1994;331:394-398.
50. Temple RT, Ellenberg SS: Placebo-controlled trials and active control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Ann Intern Med 2000;133:455-463.
51. Shapiro AK, Shapiro E: The placebo: Is it much ado about nothing? In: Harrington A (ed): The Placebo Effect. Cambridge: Harvard University Press, 1998.
52. World Medical Association International Code of Medical Ethics; amended by the 35th World Medical Assembly, October, 1983, 2000, Venice, Italy.
53. Broomhead A, Kerr R, Tester W, et al: Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain. J Pain Symptom Manage 1997;14:63-73.
54. Maxon HRd, Schroder LE, Hertzberg VS, et al: Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: Results of a double-blind crossover comparison with placebo. J Nucl Med 1991;32:1877-1881.
55. Dhaliwal HS, Sloan P, Arkinstall WW, et al: Randomized evaluation of controlled-release codeine and placebo in chronic cancer pain. J Pain Symptom Manage 1995;10:612-623.
56. Polati E, Finco G, Gottin L, Bassi C, Pederzoli P, Ischia S: Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg 1998;85:199-201.
57. Haak van der Lely F, Burm AG, van Kleef JW, et al: The effect of epidural administration of alfentanil on intra-operative intravenous alfentanil requirements during nitrous oxide-oxygen-alfentanil anaesthesia for lower abdominal surgery. Anaesthesia 1994;49: 1034-1038.
58. Hahn AF, Bolton CF, Pillay N, et al: Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 1996;119:1055-1066.
59. Dyregrov K: Bereaved parents' experience of research participation. Soc Sci Med 2004;58:391-400.
60. Cook AS, Bosley G: The experience of participating in bereavement research: stressful or therapeutic? Death Studies 19:157-170.
61. Takesaka J, Crowley R, Casarett D: What is the risk of distress in palliative care survey research? J Pain Symptom Manage 2004;28(6):593-598.
62. Bruera E: Ethical issues in palliative care research. J Palliat Care 1994;10:7-9.
63. Emanuel EJ, Fairclough DL, Slutsman J, Alpert H, Baldwin D, Emanuel LL: Assistance from family members, friends, paid care givers, and volunteers in the care of terminally ill patients. NEJM 1999;341:956-963.
64. Grisso T, Appelbaum PS: Assessing Competence to Consent to Treatment. New York: Oxford University Press, 1998.
65. Marson DC, Schmitt FA, Ingram KK, Harrell LE: Determining the competency of Alzheimer patients to consent to treatment and research. Alzheimer Dis Assoc Disord 1994;8(Suppl 4):5-18.
66. Appelbaum PS, Grisso T, Frank E, O'Donnell S, Kupfer D: Competence of depressed patients for consent to research. Am J Psychiatry 1999;156:1380-1384.
67. Weinrich S, Sarna L: Delirium in the older patient with cancer. Cancer 1994;74:2079-2091.
68. Breitbart W, Bruera E, Chochinov H, Lynch M: Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage 1995;10:131-141.
69. Pereira J, Hanson J, Bruera E: The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997;79:835-842.
70. Choo V: Thin line between research and audit. Lancet 1998;352:337-338.
71. Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M: Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 1995;10: 287-291.
72. Breitbart W, Marotta R, Platt MM, et al: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231-237.
73. Elliott C: Caring about risks: Are severely depressed patients competent to consent to research? Arch Gen Psychiatry 1997;54:113-116.
74. Casarett D, Karlawish J, Hirschman K: Identifying ambulatory cancer patients at risk of impaired capacity to consent to research. J Pain Symptom Manage 2003;26:615-626.
75. Eisenach JC, DuPen S, Dubois M, Miguel R, Allin D: Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain 1995;61:391-399.
76. Kristjanson LJ, Hanson EJ, Balneaves L: Research in palliative care populations: Ethical issues. J Palliat Care 1994:1010-1015.
77. Dresser R: Bound to treatment: The Ulysses contract. Hastings Center Rep 1984;14:13-16.
78. Miller CK, O'Donnell DC, Searight HR, Barbarash RA: The Deaconess Informed Consent Comprehension Test: An assessment tool for clinical research subjects. Pharmacotherapy 1996;16:872-878.
79. Casarett D: Assessing decision-making capacity in the setting of palliative care research. J Pain Symptom Manage 2003;25:S6-S13.
80. Hoffman M, Xu JC, Smith C, et al: A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain. Cancer Invest 1997;15:542-547.
81. High DM, Whitehouse PJ, Post SG, Berg L: Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. Alzheimer Dis Associat Disord 1994;8:66-74.
82. Beauchamp TL, Childress JF: Principles of Biomedical Ethics. 2nd ed. Oxford: Oxford University Press; 2001.